Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort.
- Authors
- Davis, Lori L; Frazier, Elizabeth; Husain, Mustafa M; Warden, Diane; Trivedi, Madhukar; Fava, Maurizio; Cassano, Paolo; McGrath, Patrick J; Balasubramani, G K; Wisniewski, Stephen R; Rush, A John
- Year
- 2006
- Journal
- The American journal on addictions
- PMID
- 16867922
- DOI
- 10.1080/10550490600754317
The demographics and clinical features were compared between those with (29.4%) and without concurrent substance use disorder (SUD) in 2541 outpatients with major depression (MDD) enrolled in the Sequenced Treatment Alternatives to Relieve Depression study. Compared to those without SUD, MDD patients with concurrent SUD were more likely to be younger, male, divorced or never married, and at greater current suicide risk, and have an earlier age of onset of depression, greater depressive symptomatology, more previous suicide attempts, more frequent concurrent anxiety disorders, and greater functional impairment (p = 0.048 to <0.0001). They were also less likely to be Hispanic and endorse general medical comorbidities (p = 0.006 and 0.002, respectively).
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of comorbid depressive syndrome and alcohol dependence. | 2012 | 22064162 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The Habenula's role in major depressive disorder: recent insights from preclinical and human studies. | Lin F et al. | β | 2026 | β |
| Investigating Alexithymia as a Moderator of Outcomes in a Randomized Controlled Trial of an Online Intervention for Co-Occurring Depression and Hazardous Alcohol Use: EnquΓͺte sur l'alexithymie en tant que modΓ©rateur des rΓ©sultats dans un essai randomisΓ© contrΓ΄lΓ© d'une intervention en ligne pour la dΓ©pression concomitante et la consommation dangereuse d'alcool. | Schell C et al. | β | 2025 | β |
| Longitudinal association of exposure to work-related stress with major depressive disorder and the role of occupational burnout in this association in the general population. | Shoman Y et al. | β | 2025 | β |
| Sex and gender differences in co-occurring substance use and depressive disorders: a systematic review. | Grant P et al. | β | 2025 | β |
| Understanding factors related to treatment retention in an online mental health support service: Analysis of a service database. | Hobden B et al. | β | 2025 | β |
| Longitudinal associations between alcohol use, smoking, genetic risk scoring and symptoms of depression in the general population: a prospective 6-year cohort study. | de Boer N et al. | β | 2023 | β |
| Neuropsychological functioning of patients with major depression or bipolar disorder comorbid to substance use disorders: A systematic review. | Miguel N et al. | β | 2023 | β |
| Clinical research challenges posed by difficult-to-treat depression. | Rush AJ et al. | β | 2022 | β |
| Depressive symptoms in early alcohol or opioid abstinence: course & correlates. | Sapkota P et al. | β | 2022 | β |
| Characteristics of depressed suicide attempters with remitted substance use disorders. | Rizk MM et al. | β | 2021 | β |
| Influence of Clinical Markers of Dopaminergic Behaviors on Depressive Symptoms During Withdrawal in Cocaine Users. | CabΓ© J et al. | β | 2021 | β |
| Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder. | Coughlin LN et al. | β | 2021 | β |
| Randomized controlled trial of online interventions for co-occurring depression and hazardous alcohol consumption: Primary outcome results. | Cunningham JA et al. | β | 2021 | β |
| Comorbid alcohol use disorder in psychiatric MDD patients: A five-year prospective study. | Holma M et al. | β | 2020 | β |
| Effect of depression on health behavior among myocardial infarction survivors in the United States. | Nicholson B et al. | β | 2020 | β |
| Pharmacological Treatment of Mood Disorders and Comorbid Addictions: A Systematic Review and Meta-Analysis: Traitement Pharmacologique des Troubles de L'humeur et des DΓ©pendances Comorbides: Une Revue SystΓ©matique et une MΓ©ta-Analyse. | Stokes PRA et al. | β | 2020 | β |
| Prevalence and Predictors of Symptoms of Depression Among Individuals Seeking Treatment from Australian Drug and Alcohol Outpatient Clinics. | Hobden B et al. | β | 2020 | β |
| Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: Systematic review and meta-analysis. | Hunt GE et al. | β | 2020 | β |
| A systematic review of technology-assisted interventions for co-morbid depression and substance use. | Holmes NA et al. | β | 2019 | β |
| Clinical Correlates of Alcohol Use Disorder in Depressed Patients with Unipolar and Bipolar Disorder. | Hong M et al. | β | 2019 | β |
| Depression in primary care: part 1-screening and diagnosis. | Ferenchick EK et al. | β | 2019 | β |
| Does providing a brief internet intervention for hazardous alcohol use to people seeking online help for depression reduce both alcohol use and depression symptoms among participants with these co-occurring disorders? Study protocol for a randomised controlled trial. | Cunningham JA et al. | β | 2018 | β |
| Health Status and Social Characteristics Among the Uninsured Using a Mental Health Free Clinic. | Kamimura A et al. | β | 2018 | β |
| Influence of comorbid alcohol use disorders on the clinical patterns of major depressive disorder: A general population-based study. | Carton L et al. | β | 2018 | β |
| Substance use comorbidity in bipolar disorder: A qualitative review of treatment strategies and outcomes. | Gold AK et al. | β | 2018 | β |
| Clinician identification of elevated symptoms of depression among individuals seeking treatment for substance misuse. | Hobden B et al. | β | 2017 | β |
| The association between tobacco, alcohol, and drug use, stress, and depression among uninsured free clinic patients: U.S.-born English speakers, non-U.S.-born English speakers, and Spanish speakers. | Kamimura A et al. | β | 2017 | β |
| The genetic basis of the comorbidity between cannabis use and major depression. | Hodgson K et al. | β | 2017 | β |
| Adolescent treatment outcomes for comorbid depression and substance misuse: A systematic review and synthesis of the literature. | Babowitch JD et al. | β | 2016 | β |
| Hazardous drinking among young adults seeking outpatient mental health services. | OrdΓ³Γ±ez AE et al. | β | 2016 | β |
| Investigation of a Suicide Ideation Risk Profile in People With Co-occurring Depression and Substance Use Disorder. | Handley TE et al. | β | 2016 | β |
| Temperament and character profiles associated with depression and treatment response in patients with or without comorbid substance abuse. | Paavonen V et al. | β | 2016 | β |
| Characteristics and differences in treatment outcome of inpatients with chronic vs. episodic major depressive disorders. | KΓΆhler S et al. | β | 2015 | β |
| Influence of comorbid alcohol use disorder on treatment response of depressive patients. | Hashimoto E et al. | β | 2015 | β |
| Dimensions of religion, depression symptomatology, and substance use among rural African American cocaine users. | Montgomery BE et al. | β | 2014 | β |
| Evaluating a brief, internet-based intervention for co-occurring depression and problematic alcohol use in young people: protocol for a randomized controlled trial. | Deady M et al. | β | 2014 | β |
| Acute and long-term treatment outcome in depressed inpatients with vs. without anxious features: results of a one-year follow-up study. | KΓΆhler S et al. | β | 2013 | β |
| Incidental treatment effects of CBT on suicidal ideation and hopelessness. | Handley TE et al. | β | 2013 | β |
| Training Addiction Counselors to Implement an Evidence-Based Intervention: Strategies for Increasing Organizational and Provider Acceptance. | Woo SM et al. | β | 2013 | β |
| A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder. | Witte J et al. | β | 2012 | β |
| Citalopram versus other anti-depressive agents for depression. | Cipriani A et al. | β | 2012 | β |
| Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial. | Davis LL et al. | β | 2012 | β |
| Genome-wide association study of comorbid depressive syndrome and alcohol dependence. | Edwards AC et al. | β | 2012 | β |
| Promoting CARE: including parents in youth suicide prevention. | Hooven C et al. | β | 2012 | β |
| Recovery from depression. | Stotland NL | β | 2012 | β |
| Suicide attempts in 107 adolescents and adults with kleptomania. | Odlaug BL et al. | β | 2012 | β |
| Suicide Risk at Young Adulthood: Continuities and Discontinuities From Adolescence. | Hooven C et al. | β | 2012 | β |
| A genomewide linkage scan of cocaine dependence and major depressive episode in two populations. | Yang BZ et al. | β | 2011 | β |
| Prevalence and correlates of alpha-delta sleep in major depressive disorders. | Jaimchariyatam N et al. | β | 2011 | β |
| Long-term outcomes for the promoting CARE suicide prevention program. | Hooven C et al. | β | 2010 | β |
| Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study. | Zisook S et al. | β | 2009 | β |
| Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. | Howland RH et al. | β | 2009 | β |
| Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. | Phelps LE et al. | β | 2009 | β |
| Initial implementation of a depression care manager model: an observational study of outpatient utilization in primary care clinics. | Angstman KB et al. | β | 2009 | β |
| Managing high-acuity-depressed adults in primary care. | Sobczak JA | β | 2009 | β |
| Pharmacogenetics studies in STAR*D: strengths, limitations, and results. | Laje G et al. | β | 2009 | β |
| [Severe depression and addictions]. | Cottencin O | β | 2009 | β |
| STAR*D: revising conventional wisdom. | Rush AJ et al. | β | 2009 | β |
| Substance use disorders in an obsessive compulsive disorder clinical sample. | Mancebo MC et al. | β | 2009 | β |
| Subtypes of major depression in substance dependence. | Niciu MJ et al. | β | 2009 | β |
| The impact of nonclinical factors on care use for patients with depression: a STAR*D report. | Kashner TM et al. | β | 2009 | β |
| Comparison of clinical characteristics of opium-induced and independent major depressive disorder. | Mowla A et al. | β | 2008 | β |
| Major depression and comorbid substance use disorders. | Davis L et al. | β | 2008 | β |
| A critical overview of the pharmacologic management of treatment-resistant depression. | Nierenberg AA et al. | β | 2007 | β |
| Preventing recurrent depression: long-term treatment for major depressive disorder. | β | β | 2007 | β |